IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $164,000 | +290.5% | 6,650 | +310.5% | 0.05% | +308.3% |
| Q2 2021 | $42,000 | -92.3% | 1,620 | -90.6% | 0.01% | -93.5% |
| Q1 2021 | $549,000 | -42.3% | 17,326 | -15.4% | 0.19% | -39.2% |
| Q4 2020 | $951,000 | -28.7% | 20,491 | -49.4% | 0.31% | -24.3% |
| Q3 2020 | $1,333,000 | +332.8% | 40,481 | +260.6% | 0.40% | +359.1% |
| Q2 2020 | $308,000 | +12.0% | 11,225 | +22.1% | 0.09% | -12.0% |
| Q1 2020 | $275,000 | – | 9,190 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |